Most importantly, in the absence of MC38-CEA tumor grafts, repeated treatments with αGC/sCD1d-anti-CEA fusion protein did not lead to significant release of cytokines, which did not differ from mice treated with the irrelevant αGC/sCD1d-anti-HER2 protein (Fig. 6d). The gene discussed is ERBB2; the disease is neoplasm.